News

DISCOVERY of a new function in a widely used anti-inflammatory drug could offer new insight into the divergent efficacies of different medications which…

London, 14 July, 2016 – The International Congress on Neuromuscular Diseases (ICND) just drew to an end in Toronto. Among the many questions addressed…

Janssen Pharmaceuticals, Inc. announced that the U.S. FDA has granted Priority Review designation for the New Drug Application for a 500mg chewable tablet formulation of mebendazole

Welcome to EMJ Neurology 4.1, an edition filled with informative and engaging content which spotlights the latest research and developments in the field…

NEW, less invasive therapy has been discovered for the treatment of prostate cancer. The therapy provides a middle ground for men who have previously had…

HIGH salt intake could lead to an increased risk of cardiovascular disease (CVD) among chronic kidney disease (CKD) patients, according to a recent study…

Holzkirchen, July 7, 2016 – Sandoz, a Novartis division, and the pioneer and global leader in biosimilars, today announced results from the EGALITY trial…

Darmstadt, Germany, July 06, 2016 – Merck, a leading science and technology company, today announced it would continue to support the advancement of…